Showing results (871-880 of 1,596) with videos related to
Sort By:
Pageof 160
Blood Pressure|May 22, 2010
Significant hyperkalemia and hyponatremia secondary to telmisartan/hydrochlorothiazide treatmentMehtap CakirBlood Pressure|May 8, 2010
Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatmentGunilla Journath, Mai-Lis Hellénius, Axel C Carlsson, et al.Blood Pressure|May 28, 2010
High prevalence of peripheral arterial disease in patients with previous cerebrovascular or coronary eventJesper Mehlsen, Niels Wiinberg, Bjarne S Joergensen, et al.Blood Pressure|May 5, 2010
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE StudyKristian Wachtell, Eva Gerdts, Gerard P Aurigemma, et al.Blood Pressure|May 14, 2009
Recurrent posterior reversible encephalopathy syndrome in mitochondrial disorderJosef Finsterer, Claudia Stöllberger, Eva Ostermann, et al.Blood Pressure|March 11, 2011
Masked hypertension unfavourably affects haemostasis parametersD P Papadopoulos, C Thomopoulos, I Mourouzis, et al.Blood Pressure|March 11, 2011
Aortic root dilatation in hypertensive patients: a multicenter survey in echocardiographic practiceCesare Cuspidi, Francesca Negri, Massimo Salvetti, et al.Blood Pressure|July 1, 1997
Endothelin-1 in heart and pulmonary tissue in experimental heart failureM L Sirviö, K Helin, P Stewen, et al.Blood Pressure|July 10, 1998
The diurnal variation in blood pressure should be calculated from individually defined day and night timesO May, H Arildsen, E M DamsgaardBlood Pressure|July 10, 1998
Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flowP E Andersson, L Lind, B Andrén, et al.Pageof 160